The Adam Watson-led APA is understood to be instead focusing – at this time – on organic opportunities within its existing ...

This year, one of the best watches unveiled at the show was a new Zenith Chronomaster Sport model. That was one of a pair of ...

The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the efficacy of Winrevair (sotatercept-csrk) in treating pulmonary arterial ...

All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.

A phase 3 trial evaluating sotatercept-csrk (Winrevair™) in adults with pulmonary arterial hypertension (PAH; World Health Organization Group 1) ...

Investors are set to reap big from the ongoing recapitalisation process as banks raised over N1.1trn through public offers ...

John Obaro, group managing director (GMD) of SystemSpecs, says the company remains dedicated to developing technology solutions for businesses and governments.

In today's episode of Fratello Talks, the guys discuss this year's LVMH Watch Week ✓ Tune in to hear about all the new releases! ✓ ...

Leaders hold the unique ability to inspire, influence, and guide companies toward practices that benefit not only their bottom line but also the environment and society ...

A Federal High Court on Wednesday set aside its Mareva orders that froze $225.8 million in assets and accounts linked ...

First Bank of Nigeria has stated that the injunctive orders granted to it by Justice Deinde Dipeolu of the Federal High Court ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on strong efficacy shown in previous studies, the drugmaker said on Thursday.